Skip to content
etf.net

Launched

F/M Emerald Life Sciences Innovation ETF

LFSCNasdaqC

$40.95−1.08 (−2.57%)

At close: Oct 13, 2026, 4:00 PM

C42/ 100

Rank 22 of 35 in US Active Sector

C42/100Rank 22 of 35inUS Active Sector
Intraday session: down, 70 prints from 42.03 to 40.95. Range 40.95 to 41.87. Use the arrow keys to read each point.41.2041.4041.6041.8010 AM12 PM2 PM4 PM
Expense ratio
0.79%
Fund size
$118M
1Y total return
+42.8%
Yield · Last 12 months
—
Holdings
38
Avg volume · 30D
0M sh
NAV per share
$42.58
52W range
low $29.55high $48.78
Launched

The ETF.net LFSC Grade

C

Score 42 out of 100

Category
US Active Sector⁠
Rank
22 of 35
Six-pillar profile for LFSC. Scores out of 100: Cost 26, Risk 39, Mission 83, Tradability 59, Holdings 71, Durability 41. Strongest: Mission (83). Weakest: Cost (26). Leans toward Mission.

Score 42 of 100 falls in the C band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    D26 out of 100
    Rank 25 of 35

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    A83 out of 100
    Rank 2 of 9

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    D39 out of 100
    Rank 24 of 35

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    B59 out of 100
    Rank 12 of 35

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    A71 out of 100
    Rank 9 of 35

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    C41 out of 100
    Rank 25 of 35

Our read on LFSC

ETF.net Research

CAn actively managed swing at life sciences innovation, launched in 2024 and priced below the typical active US equity fund. Healthcare stock-picking in a single ticket, not a sector index.

Stated mandate

The fund is intended to provide exposure to the healthcare sector, primarily through the F/m Emerald Life Sciences Innovation ETF.

Why people hold it

  1. 010.54% buys active healthcare management for less than the median active US equity fund charges, so the stock-picking doesn't start in a fee hole.
  2. 02The portfolio sticks closely to the healthcare mandate in its filings. What the documents describe is what shows up in the holdings.
  3. 03One ticket for a specialist life sciences sleeve run by a manager making calls, rather than a rules-based sector index rebalancing on a calendar.

Worth knowing

  1. 01Thinly traded, with a modest asset base. Spreads can run wider than on giant sector funds, which makes limit orders and quiet mid-session windows worth the attention.
  2. 02Launched in October 2024, so the track record is short and any read on its risk behavior rests on limited history.
  3. 03This is a total-return vehicle, not an income one. It has not been paying distributions.

LFSC Holdings

As of Oct 12, 2026
Asset class
Stocks
Holdings
38
Top-10 weight
54%
Largest holding
CORT7.8%

Geography

  • United States93.07%
  • United Kingdom6.93%
The fund’s holdings, weight-ordered — page 1 of 3.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001CORTCorcept Therapeutics Inc7.84%75,436$9M149
002LIVNLivaNova PLC6.93%105,381$8M127
003TVTXTravere Therapeutics Inc6.30%140,245$7M109
004COGTCogent Biosciences Inc6.03%235,467$7M84
005SYRESpyre Therapeutics Inc5.27%71,476$6M94
006GHGuardant Health Inc5.21%37,716$6M175
007REPLReplimune Group Inc4.59%408,338$5M55
008BLLNBilliontoone Inc4.36%54,115$5M34
009MANEVeraDermics Inc3.85%37,030$4M58
010MIRMMirum Pharmaceuticals Inc3.65%49,574$4M86
011CYTKCytokinetics Inc3.37%62,691$4M134
012TMDXTransMedics Group Inc3.34%50,164$4M110
013AXSMAxsome Therapeutics Inc3.26%22,951$4M106
014ICUIICU Medical Inc2.85%20,343$3M110
015SVRASavara Inc2.83%677,875$3M57

Showing 1–15 of 38 holdings

LFSC Performance

Launched Oct 30, 2024

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.Not enough history yet.
LFSC$14,277
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. LFSC $14,277. SPY $12,044. Use the arrow keys to read each point.$9,230$13,110$16,989Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for LFSC. Periods over one year show the average yearly return.
PeriodLFSC
Year to date+14.8%
1 month−7.3%
3 months−9.2%
1 year+42.8%
3 yearsFund is under 3 years oldper year—
5 yearsFund is under 5 years oldper year—
10 yearsFund is under 10 years oldper year—

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for LFSC
YearReturn barLFSC
2026 YTD+14.8%
2025+56.5%
2024−6.4%

Since listing, Oct 30, 2024

LFSC in the news

Filtered to LFSC · US Active Sector

LFSC Dividends

This fund pays no distributions.
—Last 12 months
Payout per share
—Last 12 months

No distributions in the last 12 months.

LFSC Risk

How much the fund’s monthly returns vary, scaled to a year.
26.3%
Annualised · 23 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
1.14
vs 3-month T-bills · 23 months to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−29.7%
23 months · trough Apr 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.94
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

LFSC Cost

Expense ratio0.79%
  • The middle half of US Active Sector funds
  • Median 0.65%

24 of the 35 US Active Sector funds charge less.

LFSC costs $79.00 a year on $10,000. The median US Active Sector fund costs $65.00.

Other funds in US Active Sector

See others